These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Cathie Wood's ARK ETFs have made their daily trades public for Thursday, January 23rd, 2025, displaying a strategic shift in ...

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...

Renowned investor Cathie Wood, CEO of Ark Invest believes President Donald Trump's second administration could breathe new ...

Despite a 15% drop in the SPDR S&P Biotech ETF, insider buying presents opportunities. Read why these small and mid-cap ...

Unlike some of the other Ark ETFs, the Innovation ETF has a broad focus, aiming to find the most innovative companies in the world. The top five holdings of the Ark Innovation ETF are Tesla, Coinbase, ...

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded ...

Sana is a gene and cell therapy clinical-stage biotech firm and a penny stock that has fallen by 48.5% in the year leading to January 17, 2025. What may set this company apart from a host of similar ...

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

There are ETFs (Exchange-Traded Funds) that focus on non-dividend stocks, although they may not specifically advertise ...

MoneywebNOW took a look at residential property challenges, ETF distributions, Reit prospects, and how AI could boost biotech under Trump’s presidency.

The sharp selloff also triggered a mass exodus from the benchmark small-cap ETF, with investors pulling more than $871 million out of IWM in the week ending Tuesday. It was also one of the three funds ...